Pascal Lefrançois, Head of Pierre Fabre Consumer Health Care commented “We are leveraging our strong position in Europe in oral and dental health products to provide an innovation in the professional management of oral lesions with the launch of Cicalium Gel & Spray.“
Marco Mastrodonato, Founder & CEO of BMG Pharma S.r.l commented – “We are very pleased with the launch of our products Aftacure Gel and Aftacure Spray, which under Pierre Fabre’s knowledge and experience in dental area will reach a large number of patients allowing them to receive fast pain relief for mouth lesions.“
About Aftacure Gel and Aftacure Spray
Aftacure Gel and Aftacure Spray have been registered in Europe as medical devices for several years and their key ingredients – PVP, taurine, zinc gluconate – form a protective barrier over the mouth, protecting it and providing pain relief while also promoting healing. Thanks to their innovative formula, Aftacure Gel and Aftacure Spray are indicated in the treatment of canker sores, irritation and lesions in the mouth due to oral surgery, traumatic ulcers caused by orthodontic devices or dentures. They act through film-forming properties, adhere to the mucosa and produce a barrier that helps to relieve pain and promote healing.
